We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-13.66%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$74.4M
AUM Growth
-$5.99M
Cap. Flow
+$9.52M
Cap. Flow %
12.79%
Top 10 Hldgs %
98.85%
Holding
39
New
2
Increased
3
Reduced
–
Closed
23

Top Buys

Rank Stock Value
1
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$1.05M
2
RZLT icon
Rezolute
RZLT
+$697K
3
ACLX
Arcellx
ACLX
+$166K
4
ELEV
Elevation Oncology
ELEV
+$35

Top Sells

Rank Stock Value
1
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$4.51M
2
ADXN
Addex Therapeutics
ADXN
+$1.35M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.1M
4
MSFT icon
Microsoft
MSFT
+$1.01M
5
INTU icon
Intuit
INTU
+$945K

Sector Composition

Rank Sector Weight
1 Healthcare 44.49%
2 Consumer Discretionary 0%
3 Consumer Staples 0%
4 Financials 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USO icon
1
CALL
United States Oil Fund
USO
$2.54B
$28.4M 38.16%
+353,500
New +$28.7M
SVRA icon
2
Savara
SVRA
$1.13B
$10.5M 14.08%
6,896,551
– –
XERS icon
3
Xeris Biopharma Holdings
XERS
$1.5B
$9.3M 12.49%
6,039,028
– –
GLD icon
4
SPDR Gold Trust
GLD
$130B
$6.88M 9.24%
40,820
– –
SPY icon
5
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$6.02M 8.08%
15,947
– –
RZLT icon
6
Rezolute
RZLT
$421M
$4.53M 6.09%
1,403,157
+209,684
+18% +$697K
SCYX icon
7
SCYNEXIS
SCYX
$44.5M
$3.21M 4.31%
215,493
– –
MTEM
8
DELISTED
Molecular Templates, Inc.
MTEM
$1.87M 2.51%
136,866
– –
ACLX
9
DELISTED
Arcellx
ACLX
$1.84M 2.47%
101,719
+12,899
+15% +$166K
VECT
10
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$1.05M 1.41%
+194,577
New +$1.05M
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$736K 0.99%
3,896
– –
ELEV
12
DELISTED
Elevation Oncology
ELEV
$96K 0.13%
68,293
+14
+0% +$35
BTWNW
13
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$10K 0.01%
39,773
– –
LUXAW
14
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$9K 0.01%
66,666
– –
PV.WS
15
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$2K ﹤0.01%
12,000
– –
FLACW
16
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$2K ﹤0.01%
21,333
– –
ADXN
17
Addex Therapeutics
ADXN
$7.52M
– –
-13,297
Closed -$1.35M
AMT icon
18
American Tower
AMT
$78.7B
– –
-3,196
Closed -$803K
CDLX icon
19
Cardlytics
CDLX
$24M
– –
-854
Closed -$470K
CHTR icon
20
Charter Communications
CHTR
$16.4B
– –
-1,210
Closed -$660K
CRM icon
21
Salesforce
CRM
$141B
– –
-3,294
Closed -$699K
CVNA icon
22
Carvana
CVNA
$50.6B
– –
-16,120
Closed -$385K
DIS icon
23
Walt Disney
DIS
$173B
– –
-5,002
Closed -$686K
FICO icon
24
Fair Isaac
FICO
$28.8B
– –
-1,715
Closed -$800K
GOOG icon
25
Alphabet (Google) Class C
GOOG
$4.32T
– –
-7,900
Closed -$1.1M
1
2

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Corporation held 39 positions worth $74.4M, down 7.4% from $80.4M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Caxton Corporation deployed $9.52M of net new capital in Q2 2022, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was VectivBio Holding AG Ordinary Shares: 194,577 shares worth $1.05M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 57% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the most notable exit was Pershing Square Tontine Holdings, Ltd., an estimated $4.51M sold.

  • Caxton Corporation's largest Q2 2022 buy was VectivBio Holding AG Ordinary Shares: 194,577 shares worth $1.05M.
  • Caxton Corporation added most to Rezolute in Q2 2022, an estimated $697K increase.
  • Caxton Corporation fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2022, selling an estimated $4.51M.
  • Caxton Corporation's ten largest holdings make up 99% of its $74.4M portfolio in Q2 2022.
  • Caxton Corporation opened 2 new positions and closed 23 in Q2 2022.
  • Caxton Corporation's portfolio value fell 7.4% quarter-over-quarter to $74.4M.

Based on Caxton Corporation's 13F filing for Q2 2022, filed 15 Aug 2022.